392 related articles for article (PubMed ID: 17884002)
1. Mucosal leishmaniasis . Current scenario and prospects for treatment.
Amato VS; Tuon FF; Bacha HA; Neto VA; Nicodemo AC
Acta Trop; 2008 Jan; 105(1):1-9. PubMed ID: 17884002
[TBL] [Abstract][Full Text] [Related]
2. New World and Old World Leishmania Infections: A Practical Review.
Kevric I; Cappel MA; Keeling JH
Dermatol Clin; 2015 Jul; 33(3):579-93. PubMed ID: 26143433
[TBL] [Abstract][Full Text] [Related]
3. Mucosal leishmaniasis: description of case management approaches and analysis of risk factors for treatment failure in a cohort of 140 patients in Brazil.
Amato VS; Tuon FF; Imamura R; Abegão de Camargo R; Duarte MI; Neto VA
J Eur Acad Dermatol Venereol; 2009 Sep; 23(9):1026-34. PubMed ID: 19453817
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of mucocutaneous leishmaniasis with pentamidine isothionate].
Amato V; Amato J; Nicodemo A; Uip D; Amato-Neto V; Duarte M
Ann Dermatol Venereol; 1998 Aug; 125(8):492-5. PubMed ID: 9747313
[TBL] [Abstract][Full Text] [Related]
5. Liposomal amphotericin B in comparison to sodium stibogluconate for cutaneous infection due to Leishmania braziliensis.
Solomon M; Baum S; Barzilai A; Scope A; Trau H; Schwartz E
J Am Acad Dermatol; 2007 Apr; 56(4):612-6. PubMed ID: 17276541
[TBL] [Abstract][Full Text] [Related]
6. Patients' associations and the control of leishmaniasis in Peru.
Guthmann JP; Calmet J; Rosales E; Cruz M; Chang J; Dedet JP
Bull World Health Organ; 1997; 75(1):39-44. PubMed ID: 9141749
[TBL] [Abstract][Full Text] [Related]
7. Comparative study on liposomal amphotericin B and other therapies in the treatment of mucosal leishmaniasis: A 15-year retrospective cohort study.
Santos CR; Tuon FF; Cieslinski J; de Souza RM; Imamura R; Amato VS
PLoS One; 2019; 14(6):e0218786. PubMed ID: 31242231
[TBL] [Abstract][Full Text] [Related]
8. Good response to pentamidine isethionate in a case of Mucosal Leishmaniasis caused by Leishmania (Viannia) braziliensis that was difficult to treat: Case Report.
Ferreira Terceiro BR; Torraca TSS; Braga FPB; Martins ACDC; Brahim LR; Saheki MN; Miranda LFC; Schubach AO; Valete-Rosalino CM
Rev Soc Bras Med Trop; 2019 Jan; 52():e20180236. PubMed ID: 30652793
[TBL] [Abstract][Full Text] [Related]
9. Leishmaniases and HIV/AIDS co-infections: review of common features and management experiences.
Ali A
Ethiop Med J; 2002 Apr; 40 Suppl 1():37-49. PubMed ID: 12802830
[TBL] [Abstract][Full Text] [Related]
10. Leishmaniasis.
Herwaldt BL
Lancet; 1999 Oct; 354(9185):1191-9. PubMed ID: 10513726
[TBL] [Abstract][Full Text] [Related]
11. Imported mucosal leishmaniasis in a traveler.
Scope A; Trau H; Bakon M; Yarom N; Nasereddin A; Schwartz E
Clin Infect Dis; 2003 Sep; 37(6):e83-7. PubMed ID: 12955668
[TBL] [Abstract][Full Text] [Related]
12. Treatment of mucosal leishmaniasis in Latin America: systematic review.
Amato VS; Tuon FF; Siqueira AM; Nicodemo AC; Neto VA
Am J Trop Med Hyg; 2007 Aug; 77(2):266-74. PubMed ID: 17690398
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms of antimony resistance in Leishmania.
Ashutosh ; Sundar S; Goyal N
J Med Microbiol; 2007 Feb; 56(Pt 2):143-53. PubMed ID: 17244793
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous leishmaniasis with secondary mucosal disease in a traveller due to Leishmania (Viannia) braziliensis.
Crone CG; Helleberg M
J Travel Med; 2020 Feb; 27(1):. PubMed ID: 31776570
[No Abstract] [Full Text] [Related]
15. Haematogenous dissemination of Leishmania (Viannia) braziliensis in human American tegumentary leishmaniasis.
de Oliveira Camera P; Junger J; do Espírito Santo Silva Pires F; Mattos M; Oliveira-Neto MP; Fernandes O; Pirmez C
Trans R Soc Trop Med Hyg; 2006 Dec; 100(12):1112-7. PubMed ID: 16765391
[TBL] [Abstract][Full Text] [Related]
16. Mucocutaneous leishmaniasis: report of a case with massive involvement of nasal, pharyngeal and laryngeal mucosa.
Di Lella F; Vincenti V; Zennaro D; Afeltra A; Baldi A; Giordano D; Pasanisi E; Bacciu A; Bacciu S; Di Lella G
Int J Oral Maxillofac Surg; 2006 Sep; 35(9):870-2. PubMed ID: 16574379
[No Abstract] [Full Text] [Related]
17. [Efficacy and tolerance of pentamidine for treatment of cutaneous leishmaniasis caused by por L. (V) panamensis in Colombia].
Robledo SM; Puerta JA; Muñoz DL; Guardo M; Vélez ID
Biomedica; 2006 Oct; 26 Suppl 1():188-93. PubMed ID: 17361854
[TBL] [Abstract][Full Text] [Related]
18. Clinical complexity of Leishmania (Viannia) braziliensis infections amongst travelers.
Eichner S; Thoma-Uszynski S; Herrgott I; Sebald H; Debus A; Tsianakas A; Ehrchen J; Harms G; Simon M; Sunderkötter C; Bogdan C
Eur J Dermatol; 2013 Apr; 23(2):218-23. PubMed ID: 23557633
[TBL] [Abstract][Full Text] [Related]
19. New world cutaneous leishmaniasis in travellers.
Schwartz E; Hatz C; Blum J
Lancet Infect Dis; 2006 Jun; 6(6):342-9. PubMed ID: 16728320
[TBL] [Abstract][Full Text] [Related]
20. Association of the Endobiont Double-Stranded RNA Virus LRV1 With Treatment Failure for Human Leishmaniasis Caused by Leishmania braziliensis in Peru and Bolivia.
Adaui V; Lye LF; Akopyants NS; Zimic M; Llanos-Cuentas A; Garcia L; Maes I; De Doncker S; Dobson DE; Arevalo J; Dujardin JC; Beverley SM
J Infect Dis; 2016 Jan; 213(1):112-21. PubMed ID: 26123565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
